Reggiardo G - Search Results

1

Discontinuation of bevacizumab and FOLFIRI administered up to a maximum of 12 cycles as first-line therapy for metastatic colorectal cancer: a retrospective Italian study.

Rosati G, Cordio S, Aprile G, Butera A, Avallone A, Di Lucca G, De Pauli F, Parra HS, Reggiardo G, Bordonaro R. Rosati G, et al. Among authors: reggiardo g. Invest New Drugs. 2012 Oct;30(5):1978-83. doi: 10.1007/s10637-011-9721-6. Epub 2011 Jul 19. Invest New Drugs. 2012. PMID: 21769636 Clinical Trial.

2

Phase II trial of oxaliplatin and tegafur/uracil and oral folinic acid for advanced or metastatic colorectal cancer in elderly patients.

Rosati G, Cordio S, Tucci A, Blanco G, Bordonaro R, Reggiardo G, Manzione L. Rosati G, et al. Among authors: reggiardo g. Oncology. 2005;69(2):122-9. doi: 10.1159/000087814. Epub 2005 Aug 23. Oncology. 2005. PMID: 16118508 Clinical Trial.

3

XELOX and bevacizumab followed by single-agent bevacizumab as maintenance therapy as first-line treatment in elderly patients with advanced colorectal cancer: the boxe study.

Rosati G, Avallone A, Aprile G, Butera A, Reggiardo G, Bilancia D. Rosati G, et al. Among authors: reggiardo g. Cancer Chemother Pharmacol. 2013 Jan;71(1):257-64. doi: 10.1007/s00280-012-2004-x. Epub 2012 Oct 26. Cancer Chemother Pharmacol. 2013. PMID: 23100174 Clinical Trial.

4

Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomized phase II study.

Rosati G, Cordio S, Bordonaro R, Caputo G, Novello G, Reggiardo G, Manzione L. Rosati G, et al. Among authors: reggiardo g. Ann Oncol. 2010 Apr;21(4):781-786. doi: 10.1093/annonc/mdp359. Epub 2009 Aug 27. Ann Oncol. 2010. PMID: 19713248 Free article. Clinical Trial.

5

A phase II study of irinotecan alternated with a weekly schedule of high-dose leucovorin and 48-hour 5-fluorouracil infusion in patients with metastatic colorectal cancer.

Rosati G, Rossi A, Reggiardo G, Manzione L. Rosati G, et al. Among authors: reggiardo g. Oncology. 2002;62(3):209-15. doi: 10.1159/000059567. Oncology. 2002. PMID: 12065867 Clinical Trial.

6

Raltitrexed and mitomycin-C as third-line chemotherapy for colorectal cancer after combination regimens including 5-fluorouracil, irinotecan and oxaliplatin: a phase II study.

Rosati G, Rossi A, Germano D, Reggiardo G, Manzione L. Rosati G, et al. Among authors: reggiardo g. Anticancer Res. 2003 May-Jun;23(3C):2981-5. Anticancer Res. 2003. PMID: 12926149 Clinical Trial.

7

A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer.

Rosati G, Tucci A, Rinaldi A, Colarusso D, Pizza C, Reggiardo G, Manzione L. Rosati G, et al. Among authors: reggiardo g. Oncology. 2004;66(5):371-8. doi: 10.1159/000079485. Oncology. 2004. PMID: 15331924 Clinical Trial.

8

Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II Trials.

Rosati G, Cordio S, Reggiardo G, Aprile G, Butera A, Avallone A, Tucci A, Novello G, Blanco G, Caputo G, Bilancia D, Bordonaro R. Rosati G, et al. Among authors: reggiardo g. Cancers (Basel). 2019 Apr 24;11(4):578. doi: 10.3390/cancers11040578. Cancers (Basel). 2019. PMID: 31022922 Free PMC article.

9

Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies in vulnerable older patients with metastatic colorectal cancer: Data from the REVOLT study.

Rosati G, Corsi D, Avallone A, Brugnatelli S, Dell'Aquila E, Cinausero M, Aprile G, Cicero G, Carlomagno C, Colombo A, Rapisardi S, Pinto C, Reggiardo G, Bilancia D. Rosati G, et al. Among authors: reggiardo g. J Geriatr Oncol. 2022 Apr;13(3):302-307. doi: 10.1016/j.jgo.2021.10.007. Epub 2021 Oct 26. J Geriatr Oncol. 2022. PMID: 34716122

10

Reduced dose intensity of docetaxel plus capecitabine as second-line palliative chemotherapy in patients with metastatic gastric cancer: a phase II study.

Rosati G, Bilancia D, Germano D, Dinota A, Romano R, Reggiardo G, Manzione L. Rosati G, et al. Among authors: reggiardo g. Ann Oncol. 2007 Jun;18 Suppl 6:vi128-32. doi: 10.1093/annonc/mdm241. Ann Oncol. 2007. PMID: 17591806 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters